Jazz Pharmaceuticals Plc Earnings

Jazz Pharmaceuticals Plc’s revenue jumped 10.09% since last year same period to $1197.93Mn in the Q4 2025. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated 6.38% jump in its revenue since last 3-months.

Jazz Pharmaceuticals Plc’s net profit jumped 6.45% since last year same period to $203.45Mn in the Q4 2025. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated -19.08% fall in its net profits since last 3-months.

Jazz Pharmaceuticals Plc’s net profit margin fell -3.3% since last year same period to 16.98% in the Q4 2025. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated -23.93% fall in its net profit margins since last 3-months.

Jazz Pharmaceuticals Plc’s earning per share (EPS) estimates for the current quarter stand at 6.51 - a 9.17% jump from last quarter’s estimates.

Jazz Pharmaceuticals Plc’s earning per share (EPS) estimates for the current year stand at 6.51.

Jazz Pharmaceuticals Plc’s earning per share (EPS) jumped 0.61% since last year same period to 6.64 in the Q4 2025. This indicates that the Jazz Pharmaceuticals Plc has generated 0.61% annual rate of jump in its earning per share (EPS) in the last 4 quarters.